InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,312.80
(
0.92%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.89
(
0.71%
)
Bitcoin
68,935.65
(
1.49%
)
Post# of 1434
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rikic

Send PM Follow Ignore
Followers 2
Posts 298
Boards Moderated 0
Alias Born 08/16/2010

rikic

Re: None

Tuesday, 04/05/2011 1:13:25 PM

Tuesday, April 05, 2011 1:13:25 PM

Post# of 1434
Aradigm Will Complete Results From Phase 2b Study
of Inhaled Ciprofloxacin for the Management of Respiratory Infections in Bronchiectasis By The End Of The Month.

Results Will Refine Protocols for Pivotal Phase 3 Trial Design.

http://www.businesswire.com/news/home/20110322005689/en/Aradigm-Completes-Enrollment-Phase-2b-Study-Inhaled
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up